NeuroSense receives South Korean patent for ALS drug PrimeC

Go back to NeuroSense receives South Korean patent for ALS drug PrimeC
(NASDAQ: NRSN) Delayed: 0.42 --0 (-0%)
Previous Close $0.42    52 Week High
Open $0.42    52 Week Low
Day High $0.42    P/E N/A 
Day Low $0.42    EPS
Volume 510       

(NASDAQ: NRSNW) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High
Open $0.05    52 Week Low
Day High $0.05    P/E N/A 
Day Low $0.05    EPS
Volume 436,165